GlucoSet is medical device company that is developing sensor technology for improved glucose control in intensive care units.
GlucoSet has raised $6.6M in total funding. The most recent round was Series A. The last funding was announced in July 2023.
GlucoSet's investors include European Innovation Council, EASME, Horizon 2020, TeleVenture Management, Swiss Diabetes Venture Fund.
GlucoSet is headquartered in Trondhjem, Norway.
GlucoSet is medical device company that is developing sensor technology for improved glucose control in intensive care units.
GlucoSet is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"GlucoSet — Funding & Investors." VCBacked, July 7, 2023, https://www.vcbacked.co/company/glucoset. Accessed July 20, 2026.
VCBacked. (2023). GlucoSet — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/glucoset
{{cite web |title=GlucoSet — Funding & Investors |url=https://www.vcbacked.co/company/glucoset |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated